( in thousand) As at 31 March ASSETS Non-current assets Current assets Total assets
|
|
|
- Harry Weaver
- 5 years ago
- Views:
Transcription
1 Balance Sheet as at 31 March 2017 Notes 31 March March April 2015 ASSETS Noncurrent assets Current assets assets EQUITY AND LIABILITIES Equity Equity share capital 1(a) Other equity 1(b) (2,207) (179) (2,207) (211) (2,207) (204) Equity attributable to equity holders of the Parent (2,206) (179) (2,206) (211) (2,206) (204) LIABILITIES Noncurrent liabilities Current liabilities Financial liabilities Trade payables 2 2, , , current liabilities 2, , , liabilities 2, , , equity and liabilities PRAKASH C BISHT CFO ( Ingredients) & Sr. VP (Group Accounts) Place: Noida Date: 22 May, 2017
2 Statement of Profit and Loss for the year ended 31 March 2017 For the year ended For the year ended Notes 31 March March 2016 Revenue from operations Expenses Profit before tax Tax expense Profit for the year Other comprehensive income Items that will be reclassified to profit or loss Exchange differences on translation of foreign operations 32 (7) Other comprehensive income for the year, net of tax 32 (7) comprehensive income for the year 32 (7) Profit is attributable to: Equity holders of the Parent Noncontrolling interests comprehensive income is attributable to: Equity holders of the Parent 32 (7) Noncontrolling interests 32 (7) PRAKASH C BISHT CFO ( LSI) & Sr. VP (Group Accounts) Place: Noida Date: 22 May, 2017
3 Notes to the financial statements for the year ended 31 March (a) Equity share capital Balance as at 1 April Additions during the year Balance as at 31 March Additions during the year Balance as at 31 March (b) Other Equity 1 April 2015 (2,207) (2,207) Profit for the year Other comprehensive income comprehensive income for the year 31 March 2016 (2,207) (2,207) 1 April 2016 (2,207) (2,207) Profit for the year Other comprehensive income comprehensive income for the year 31 March 2017 (2,207) (2,207)
4 Notes to the financial statements for the year ended 31 March (a) Equity share capital Balance as at 1 April 2015 Additions during the year Balance as at 31 March 2016 Additions during the year Balance as at 31 March (b) Other Equity 1 April 2015 (204) (204) Profit for the year Other comprehensive income (7) (7) comprehensive income for the year (7) (7) 31 March 2016 (204) (7) (211) 1 April 2016 (204) (7) (211) Profit for the year Other comprehensive income comprehensive income for the year March 2017 (204) 25 (179)
5 Notes to the financial statements for the year ended 31 March (c). SHARE CAPITAL Authorized 1,000 (31 March 2016: 1,000; 1 April 2015: 1,000) equity shares of 1 each 1, , ,000 Issued, Subscribed & Paid up 1 (31 March 2016: 1 ; 1 April 2015: 1 ) equity shares of 1 each (i) The Company has only one class of shares referred to as equity shares having par value of 1. Each holder of equity shares is entitled to one vote per share. (ii) In the event of liquidation of the Company, the holders of equity shares will be entitled to receive any of the remaining assets of the Company, after distribution of all preferential amounts. However, no such preferential amounts exist currently. The distribution will be in proportion to the number of equity shares held by the shareholders. (iii) The details of shareholders holding more than 5% shares is set out below: Name of the shareholder No of shares % holding No of shares % holding No of shares % holding Jubilant Draximage Inc, Canada (iv) Shares held by holding company/ultimate holding company and/or their subsidiaries/associates Out of the equity Shares issued by the company, shares held by it's holding company/ultimate holding company and/or their subsidiaries/associates are as below: Name of the shareholder No of shares No of shares No of shares Jubilant Draximage Inc, Canada (v) The reconciliation of the number of shares outstanding is set out below: Particulars No of shares No of shares No of shares Numbers of shares at the beginning Add: Shares issued during the year Numbers of shares at the end 1 1 1
6 2. Trade payables 31 March March April 2015 Current Trade payables 2, , , trade payables 2, , ,
Draximage Limited, Ireland Balance Sheet as at 31 March 2017
Balance Sheet as at Notes thousand) thousand) thousand) 31 March 2016 01 April 2015 ASSETS Current assets Financial assets Cash and cash equivalents 1 (a) 341,362 22,137 11,511 763 20,503 1,281 Other financial
As at. As at 31 March 2017
Balance Sheet as at 31 March 2017 Euro ( in thousand) Notes 31 March 2017 31 March 2016 01 April 2015 ASSETS Non-current assets Financial assets i. Investments 1(a) 17,961,400 1,244,545 17,961,400 1,354,290
Jubilant DraxImage (USA) Inc. Balance Sheet as at 31 March 2017
Balance Sheet as at Notes ASSETS Non-current assets Advance payment of income tax 38,444 2,493 22,400 1,485 - - Total 38,444 2,493 22,400 1,485 - - Current assets Financial assets i. Trade receivables
Jubilant Innovation (BVI) Ltd. INR (' In Thousands) As at 31 March INR (' In Thousands) As at 31 March 2017
Balance Sheet as at Notes 1 April 2015 ASSETS Non-current assets Financial assets i. Non-current investments 4,031,314 261,431 4,031,314 267,075 3,213,314 200,832 non-current assets 4,031,314 261,431 4,031,314
Jubilant Hollister Stier Inc Balance Sheet as at 31 March 2017
Balance Sheet as at 31 March 2017 Notes 31 March 2017 31 March 2016 01 April 2015 ASSETS Non-current assets Non-current investments 1 94,313,122 6,116,206 97,158,062 6,436,722 103,704,274 6,481,517 Deferred
Jubilant Innovation (USA) Inc. INR (' In Thousands) As at 31 March INR (' In Thousands) As at 31 March 2017
Balance Sheet as at Notes 01 April 2015 ASSETS Non-current assets Financial assets i. Non-current investments 1 3,221,098 208,888 4,190,304 277,608 2,600,000 162,500 Income tax asset (net) - - - - 22,826
Jubilant Drug Discovery and Development Services Inc. INR (' In Thousands) As at 31 March INR (' In Thousands) As at 31 March 2017
Balance Sheet as at Notes ASSETS Non-current assets Property, plant and equipment 1 66,694 3,241 - - - - Income tax asset (net) 332 16 332 17 - - Total non-current assets 67,026 3,257 332 17 - - Current
JUBILANT PHARMA TRADING INC Balance Sheet As at 31st Mar Notes No USD INR (' In Thousands)
Balance Sheet As at 31st Mar Notes No 2015 2015 I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 100 6 Reserves & surplus 2 487,663 30,479 487,763 30,485 Current liabilities Trade payables
Euro ( in thousand) As at. As at 31 March 2017
Balance Sheet as at 31 March 2017 Notes 31 March 2017 31 March 2016 01 April 2015 ASSETS Non-current assets Property, plant and equipment 1(a) - - - - 599 40 Intangible assets 1(b) - - - - 63 4 Financial
USD ( in thousand) As at 31 March March Notes
( in ( in USD USD Balance Sheet as at thousand) thousand) USD ( in thousand) Notes ASSETS Non-current assets Property, plant and equipment 1 513,437 33,294 354,249 23,469 328,775 20,548 Capital work in
As at. As at 31-Mar-17
Balance Sheet as at 31 March 2017 USD ( in thousand) Notes 31-Mar-17 31-Mar-16 1-Apr-15 ASSETS Non-current assets Property, plant and equipment 1 244,806 15,875 206,882 13,705 - - Capital work-in-progress
JUBILANT LIFE SCIENCES (SWITZERLAND) AG Balance Sheet
Balance Sheet Notes No I. EQUITY AND LIABILITIES Shareholders' Funds Share Capital 1 100,000 4,697 100,000 4,697 Reserves & Surplus 2 (87,336) (3,883) (76,984) (3,136) 12,664 814 23,016 1,561 Current liabilities
DRAXIMAGE LIMITED, IRELAND
Balance Sheet As at 31st March, I. EQUITY AND LIABILITIES Shareholders' Funds Share Capital Reserves & Surplus Note No 1 2 2014 2013 7,00,004 33,479 7,00,004 33,479 (2,99,300) (9,473) (2,73,427) (10,321)
JUBilANT DRAXIMAGE {USA) INC
JUBilANT DRAXIMAGE {USA) INC Balance Sheet As at 31st March, I. EQUITY AND liabilities Shareholders' Funds Share Capital Reserves & Surplus Note No 1 2 2014 2013 USD ~in OOO's USD ~in OOO's 9 0 9 0 (1,11,676)
JUBILANT LIEF SCIENCES NV Balance Sheet As at 31st Mar Notes No EUR INR (' In Thousands) EUR INR (' In Thousands)
Balance Sheet As at 31st Mar Notes No 2015 2015 2014 2014 I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 100,000 7,808 100,000 7,808 Reserves & surplus 2 (73,598) (6,034) (414,698) (33,827)
PSI SUPPLY NV
Balance Sheet as at 31 March, Note No. I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 665,000 43,372 665,000 43,372 Reserves and surplus 2 (385,012) (22,258) 162,737 12,250 279,988 21,114
JUBILANT DISCOVERY SERVICES INC USD in '000 USD in '000
Balance Sheet as at 31st March, Note No I. EQUITY AND LIABILITIES Shareholders' Funds Share Capital 1 2,485,000 116,875 2,485,000 116,875 Reserves & Surplus 2 (2,642,347) (126,706) (2,756,755) (133,156)
As at 31st Mar Notes No USD INR (' In Thousands) USD INR (' In Thousands)
Balance Sheet As at 31st Mar Notes No 2015 2015 2014 2014 I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 2 2,165,000 107,702 2,110,000 104,966 Reserves & surplus 3 (24,438) 26,083 20,623 22,679
JUBILANT INNOVATION USA INC. Balance Sheet. As at 31st Mar Notes No USD INR (' In Thousands)
Balance Sheet As at 31st Mar Notes No. 2016 2016 2015 2015 I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 2,975,000 160,038 2,165,000 107,702 Reserves and surplus 2 2,429,441 198,007 (24,438)
As at. As at 31-Mar-17
Balance Sheet as at Notes 31-Mar-17 31-Mar-16 1-Apr-15 ASSETS Non-current assets Property, plant and equipment 1(a) 73,473,714 4,764,770 75,732,710 5,017,292 76,033,917 4,752,120 Capital work-in-progress
CADISTA HOLDINGS INC BALANCE SHEET
BALANCE SHEET As at 31 March, I. EQUITY AND LIABILITIES Shareholders' Funds Share capital Reserves and surplus Current liabilities Note No. l 2 2014 2013 117,797 5,399 117,797 5,399 33,501,432 2,008,728
JUBILANT DRUG DEVELOPMENT PTE LIMITED Balance Sheet As at 31st Mar Notes No USD INR (' In Thousands) USD INR (' In Thousands)
Balance Sheet As at 31st Mar Notes No 2015 2015 2014 2014 USD INR (' In Thousands) USD INR (' In Thousands) I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 Reserves & surplus 2 (74,910) 27,173
JUBILANT LIFE SCIENCE (BVI) LIMITED Balance Sheet As at 31st Mar Notes No USD INR (' In Thousands) USD INR (' In Thousands)
Balance Sheet As at 31st Mar Notes No 2015 2015 2014 2014 I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 Reserves & surplus 2 (31,375) 47,527 (25,505) 37,671 3,941,126 246,320 3,946,996
!Notes No 1,371,501 68,559 1,356,501 67,754 (61,175) 9,942 {49,315) 3,214. Total
JUBilANT BIOSYS (SINGAPORE) PTE ltd Balance Sheet I. EQUITY AND liabilities Shareholders' Funds Share capital Reserves & surplus Money received against share warrants Current liabilities Trade payables
JUBILANT DRAXIMAGE INC., CANADA
Balance Sheet As at 31st March, I Note No 2014 2013 CAD ~ (In Lakhs) CAD ~ (In Lakhs) I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 13,03,65,215 56,899 13,03,65,215 56,899 Reserves & surplus
Jubilant Draximage Limited Balance Sheet as at 31 March 2017 (INR in thousands) As at 31 March 2017
Balance Sheet as at Notes 1 April 2015 ASSETS Non-current assets Property, plant and equipment 3 498 626 159 Other intangible assets 4 - - 2 Financial assets i. Loans 5(b) 82 37 22 ii. Other financial
Notes No 2014 RMB 1 1,652, ,096,459 31,749, ,410, , ,273, ,597, ,346, , , , ,793
JUBILANT LIFE SCIENCES (SHANGHAI) ltd Balance Sheet As at 31st Mar Notes No 2014 2014 2013 2013 INR (' In Thousands) INR (' In Thousands) I. EQUITY AND LIABILITIES Shareholders' Funds Share capital Reserves
As at 31 March, Notes No
Balance Sheet As at 31 March, Notes No. 2016 2016 2015 2015 I. EQUITY AND LIABILITIES Shareholders' Funds Share capital 1 21,521,278 876,777 21,521,278 876,777 Reserves and surplus 2 26,139,908 2,280,776
Jubilant Clinsys Limited Balance Sheet as at 31 March 2017 ( in thousands) Notes
Balance Sheet as at 31 March 2017 Notes As at As at As at 31 March 2017 31 March 2016 1 April 2015 ASSETS Noncurrent assets Property, plant and equipment 3 1,907 2,590 4,655 Intangible assets 4 209 548
JUBILANT INNOVATION USA INC Balance Sheet as at Note No 31-Mar Mar-13
Balance Sheet as at Note No 31-Mar-14 31-Mar-13 USD {INR'OOO) USD {INR'OOO) I. EQUITY AND LIABILITIES Shareholders' Funds Share Capital 1 2,110,000 104,966 1,110,000 55,219 Reserves & Surplus 2 20,623
Jubilant Chemsys Limited Balance Sheet as at 31 March 2017 ASSETS
Balance Sheet as at (INR In Thousands) Notes ASSETS Non-current assets Property, plant and equipment 3 226,627 216,462 181,566 Capital work-in-progress 3 8,266 1,671 72,058 Other intangible assets 4 1,358
so,ooo 2,452 50,000 2,452
Balance Sheet As At I. EQUITY AND LIABILITIES Shareholders' Funds Note No Share Capital 1 Reserves & Surplus 2 Current liabilities Trade Payables 3 Other Current liabilities 4 Short-term provisions 5 31-Mar-14
Consolidated Balance Sheets
page 77 Consolidated Balance Sheets Toyota Motor Corporation March 31, 2011 and 2012 ASSETS 2011 2012 2012 Current assets Cash and cash equivalents 2,080,709 1,679,200 $ 20,431 Time deposits 203,874 80,301
CONSOLIDATED US GAAP FINANCIAL STATEMENTS FOR MARCH 31, 2017
CONSOLIDATED US GAAP FINANCIAL STATEMENTS FOR MARCH 31, 2017 Contents: CONSOLIDATED INCOME STATEMENTS CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME CONSOLIDATED BALANCE SHEETS CONSOLIDATED STATEMENTS
(Expressed in Thousands of New Taiwan Dollars)
4 (English Translation of Consolidated Financial Statements and Report Originally Issued in Chinese) as of March 31, 2017 and 2016 Consolidated Balance Sheets March 31, 2017, December 31, 2016, and March
Jubilant Infrastructure Limited Ind AS financial statements March 2017
Ind AS financial statements March 2017 Balance Sheet as at Notes 1 April 2015 ASSETS Non-current assets Property, plant and equipment 3 1,459,327 1,354,722 1,227,256 Capital work-in-progress 3 11,073 24,708
(Expressed in Thousands of New Taiwan Dollars)
Consolidated Balance Sheets, 2017, December 31, 2016, and, 2016, 2017 December 31, 2016 (Audited), 2016 Assets Amount % Amount % Amount % Current assets: 1100 Cash and cash equivalents $ 27,532,003 18
CONSOLIDATED US GAAP FINANCIAL STATEMENTS FOR SEPTEMBER 30, 2016
CONSOLIDATED US GAAP FINANCIAL STATEMENTS FOR SEPTEMBER 30, 2016 Contents: CONSOLIDATED INCOME STATEMENTS CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME CONSOLIDATED BALANCE SHEETS CONSOLIDATED STATEMENTS
Independent Auditor's Report
Independent Auditor's Report 182 To the Members of Report on the Audit of Consolidated Ind AS Financial Statements We have audited the accompanying consolidated Ind AS financial statements of (hereinafter
HYUNDAI ELEVATOR CO., LTD. and Subsidiaries Consolidated Statements of Financial Position December 31, 2013 and 2012
Consolidated Statements of Financial Position December 31, 20 and 2012 (in Korean won) Notes 20 2012 Assets Current assets Cash and cash equivalents 4,5 114,983,668,303 259,999,021,577 Shortterm financial
JUBILANT DRAXIMAGE LIMITED Balance Sheet As at 31 March, 2015 Note As at 31 March 2015 As at 31 March 2014
Balance Sheet As at 31 March, 2015 (Rs '000) Note As at As at I. EQUITY AND LIABILITIES Shareholders' funds Share capital 2 781 781 Reserves and surplus 3 (30,734) (26,892) (29,953) (26,111) Non-current
ACER INCORPORATED AND SUBSIDIARIES Consolidated Balance Sheets June 30, 2018, December 31, 2017, and June 30, 2017
Reviewed only, not audited in accordance with the generally accepted auditing standards as of June 30, 2018 and 2017 Consolidated Balance Sheets June 30, 2018, December 31, 2017, and June 30, 2017 June
DANA HOLDING CORPORATION Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures
Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures Non-GAAP Financial Measures Adjusted EBITDA is a non-gaap financial measure which we have defined as earnings from continuing
Jubilant First Trust Healthcare Limited Balance Sheet as at 31 March 2016
Balance Sheet as at 31 March 2016 (Rs. '000) Note As at 31 March 2016 As at 31 March 2015 EQUITY AND LIABILITIES Shareholder's funds Share capital 2 20,500 156,132 Reserves and surplus 3 46,622 581,899
Disclosure on transition to IFRS
- 13 - Disclosure on transition to The Company adopted in preparing its consolidated financial statements for the fiscal year ended March 31, 2017. The date of transition to is April 1, 2015. (1) First-time
FAR EASTERN NEW CENTURY CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (In Thousands of New Taiwan Dollars) June 30, 2015 (Reviewed) December 31, (Audited after Restated) June 30, January 1, (Audited after Restated) ASSETS Amount % Amount % Amount
Total assets 936,270, ,919,862
Condensed Consolidated Statement of Financial Position - - As at September 30, 2017 As at March 31, 2017 ASSETS Non-current assets Property, plant and equipment 283,303,778 262,522,265 Goodwill 166,278,505
Jubilant Pharma Limited Condensed Consolidated Statement of Financial Position (All amounts in USD, unless otherwise stated) - As at 30 September 2018
Condensed Consolidated Statement of Financial Position - 31 March 2018 ASSETS Non-current assets Property, plant and equipment 274,233,408 278,365,913 Goodwill 167,075,796 168,634,149 Other intangible
June 24, Earnings per common share Basic $ 4.08 $ 3.31 $ 8.13 $ 6.03 Diluted $ 4.05 $ 3.28 $ 8.07 $ 5.97
Consolidated Statements of Earnings 1 (unaudited; in millions, except per share data) Quarters Ended Net sales $ 13,398 $ 12,563 $ 25,033 $ 23,775 Cost of sales (11,645) (10,907) (21,622) (20,713) Gross
Condensed Consolidated Interim Financial Statements as of September 30, 2018
Bayer Interim Report as of September 30, 208 Condensed Consolidated Interim Financial Statements 29 Bayer Group Consolidated Income Statements Condensed Consolidated Interim Financial Statements as of
PRAKRUTI COMMERCIALS PRIVATE LIMITED. Prakruti Commercials Private Limited
PRAKRUTI COMMERCIALS PRIVATE LIMITED 707 Prakruti Commercials Private Limited 708 PRAKRUTI COMMERCIALS PRIVATE LIMITED Balance Sheet as at 31st March, 2015 Notes As at As at 31st March, 2015 31st March,
For B S R & Co. LLP Chartered Accountants Firm Registration Number: W. For and on behalf of the Board of Directors of Jubilant Generics Limited
Balance Sheet as at 31 March 2014 EQUITY AND LIABILITIES Shareholders' funds Share capital Reserves and surplus Note As at 31 March 2014 (INR'OOO) 3 1,000 4 (407) 593 Current liabilities Trade payables
Sept. 30, Earnings per common share Basic $ 5.18 $ 3.35 $ $ 9.38 Diluted $ 5.14 $ 3.32 $ $ 9.29
Consolidated Statements of Earnings 1 (unaudited; in millions, except per share data) Quarters Ended Net sales $ 14,318 $ 12,341 $ 39,351 $ 36,116 Cost of sales (12,397) (10,741) (34,019) (31,454) Gross
EMERSON AND SUBSIDIARIES CONSOLIDATED OPERATING RESULTS (AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED)
CONSOLIDATED OPERATING RESULTS (AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED) Table 1 Quarter Ended March 31 Percent Change Net sales $3,579 $3,574 % Costs and expenses: Cost of sales 2,037 2,017 SG&A
638 NISARGA COMMERCIALS PRIVATE LIMITED. Nisarga Commercials Private Limited
638 NISARGA COMMERCIALS PRIVATE LIMITED Nisarga Commercials Private Limited NISARGA COMMERCIALS PRIVATE LIMITED 639 Balance Sheet as at 31st March, 2015 Notes As at As at 31st March, 2015 31st March, 2014
\WIPRO TECHNOLOGIES SPAIN STANDALONE FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED MARCH 31, 2015
\WIPRO TECHNOLOGIES SPAIN STANDALONE FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED MARCH 31, 1 WIPRO TECHNOLOGIES SPAIN BALANCE SHEET AS AT MARCH 31, (Amount in INR, except share and per share data,
Balance Sheet (Thousands of yen)
Balance Sheet As of As of Assets Current assets Cash and deposits 1,948,490 2,364,338 Notes and accounts receivable - trade 877,408 854,811 Electronically recorded monetary claims - operating 3,328 11,512
31,114 29,213 ASSETS Non-current assets Fixed Assets Tangible assets Intangible assets 6-92 Long-term loans and advances ,095
Vanthys Pharmaceutical Development Private Limited Balance Sheet as at Note (Rs '000) EQUITY AND LIABILITIES Shareholders' funds Share capital 2 225,000 225,000 Reserves and surplus 3 (194,437) (196,211)
CLOSED JOINT STOCK COMPANY KYRGYZ INVESTMENT AND CREDIT BANK
CLOSED JOINT STOCK COMPANY KYRGYZ INVESTMENT AND CREDIT BANK Consolidated Financial Statements and Independent Auditor s Report For the year ended 2014 CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER
JUBILANT LIFE SCIENCES Q4 & FY2016 RESULTS
PRESS RELEASE Noida, Tuesday, May 24, 2016 Jubilant Life Sciences Ltd. 1A, Sector 16A, Noida 201301, India Tel.: +91 120 4361000 http://www.jubl.com JUBILANT LIFE SCIENCES Q4 & FY2016 RESULTS JUBILANT
100 CHITRANI MERCANTILE PRIVATE LIMITED. Chitrani Mercantile Private Limited
100 CHITRANI MERCANTILE PRIVATE LIMITED Chitrani Mercantile Private Limited CHITRANI MERCANTILE PRIVATE LIMITED 101 Balance Sheet as at 31st March, 2015 Notes As at As at 31st March, 2015 31st March, 2014
NEMITA COMMERCIALS PRIVATE LIMITED. Nemita Commercials Private Limited
567 Nemita Commercials Private Limited 568 NEMITA COMMERCIALS PRIVATE LIMITED Balance Sheet as at 31st March, 2015 Notes As at As at 31st March, 2015 31st March, 2014 EQUITY AND LIABILITIES Shareholders
Supplemental Financial Data and GAAP to Non-GAAP Reconciliations Second Quarter 2018
Supplemental Data and GAAP to Non-GAAP Reconciliations Second Quarter 2018 2017 FIS and/or its subsidiaries. All Rights Reserved. Fidelity National Information Services, Inc. Earnings Release Supplemental
ACER INCORPORATED AND SUBSIDIARIES. Consolidated Balance Sheets
Consolidated Balance Sheets June 30, 2016, December 31, 2015 and June 30, 2015 (June 30, 2016 and 2015 are reviewed, not audited) Assets 2016.6.30 2015.12.31 2015.6.30 Current assets: Cash and cash equivalents
Consolidated Balance Sheets
Consolidated Balance Sheets March 31, 2008 and 2009 ASSETS 2008 2009 2009 Current assets Cash and cash equivalents... 1,628,547 2,444,280 $ 24,883 Time deposits... 134,773 45,178 460 Marketable securities...
TATE & LYLE PLC EFFECT OF ADOPTION OF IFRS 11 JOINT ARRANGEMENTS
29 May 2014 ACCOUNTING FOR JOINT VENTURES With effect from 1 April 2014, Tate & Lyle adopted IFRS 11 Joint Arrangements which will change significantly the basis of accounting for its interests in joint
INVESTOR SUMMARY. 3Q13 - November 12, 2013
QUARTERLY INVESTOR SUMMARY 3Q13 - November 12, 2013 DISH NETWORK REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS ENGLEWOOD, Colo., Nov. 12, 2013 DISH Network Corporation (NASDAQ: DISH) today reported revenue
Reliance Defence and Aerospace Private Limited. Accounts for the year ended on March 31, 2016
Accounts for the year ended on March 31, 2016 Balance Sheet as at March 31, 2016 Note No. I. EQUITY AND LIABILITIES Shareholders' funds (a) Share Capital 2 1,00,000 1,00,000 (b) Reserves and Surplus 3
FINANCIAL STATEMENTS
FINANCIAL STATEMENTS Consolidated Income Statement 35 Consolidated Statement of Comprehensive Income 36 Consolidated Statement of Financial Position 37 Consolidated Statement of Changes In Equity 38 Consolidated
Idorsia Financial Report
0 Idorsia Financial Report as of 30 September 2017 Contents 3 11 Financial review Interim unaudited consolidated financial statements 3 Financial review Idorsia s key numbers Profit and loss Period ended
ACCENTURE PLC RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC)
RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC) For the February 28, 2011 ROIC represents Return on Invested Capital and is equal to the tax adjusted operating income divided by total average capital,
ACCENTURE PLC RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC)
RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC) For the November 30, 2010 ROIC represents Return on Invested Capital and is equal to the tax adjusted operating income divided by total average capital,
2
News Release 1 2 3 4 5 6 Ashland Global Holdings Inc. and Consolidated Subsidiaries Table 1 STATEMENTS OF CONSOLIDATED INCOME (In millions except per share data - preliminary and unaudited) Three months
QUARTERLY INVESTOR SUMMARY
QUARTERLY INVESTOR SUMMARY August 5, 2015 DISH NETWORK REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS ENGLEWOOD, Colo., August 5, 2015 DISH Network Corp. (NASDAQ: DISH) today reported revenue totaling $3.83
Senvion S.A., Luxembourg Interim Report as of March 31, January 1, 2018 March 31, 2018
+ Senvion S.A., Luxembourg Interim Report as of March 31, 2018 January 1, 2018 March 31, 2018 Senvion S.A., Interim Report March 31, 2018 2 Key Financials First time adoption of new accounting standards
Summary of Accounting Report for the Fiscal Year Ended March 2018(IFRS) (April 1, 2017 March 31, 2018)
June 22, 2018 Company Representative Contact JVCKENWOOD Corporation Takao Tsuji, Representative Director of the Board, Chairman & CEO (Code: 6632; First Section of the Tokyo Stock Exchange) Masatoshi Miyamoto,
ACCENTURE PLC RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC) For the Twelve Months Ended May 31, 2012 (in millions of U.S. dollars) (Unaudited)
RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC) For the ROIC represents Return on Invested Capital and is equal to the tax adjusted operating income divided by total average capital, as outlined below.
ACCENTURE PLC RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC) For the Twelve Months Ended May 31, 2011 (in millions of U.S. dollars) (Unaudited)
RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC) For the ROIC represents Return on Invested Capital and is equal to the tax adjusted operating income divided by total average capital, as outlined below.
Consolidated Statement of Income (unaudited)
Deutsche Bank Consolidated Financial Statements 79 Interim Report as of September 0, 05 Consolidated Statement of Income (unaudited) Consolidated Statement of Income (unaudited) Income Statement Three
Daimler 2012 Reference Information
REFERENCE INFORMATION 1 Daimler 2012 Reference Information TABLE OF CONTENTS Financial statements 2 Provisions for other risks (including warranties) 6 2 NAVIGATING ACCOUNTING Financial statements Consolidated
Years Ended Dec. 31,
Consolidated Statements of Earnings (unaudited; in millions, except per share data) Net sales $ 14,411 $ 13,844 $ 53,762 $ 49,960 Cost of sales 1 (12,469) (12,135) (46,488) (43,589) Gross profit 1,942
Consolidated Financial Summary (For the First Quarter Ended June 30, 2015 (IFRS basis))
Consolidated Financial Summary (For the First Quarter Ended June 30, 2015 (IFRS basis)) Listed company: Hitachi Chemical Co., Ltd. July 29, 2015 (Code number: 4217 Stock exchange: Tokyo) (URL http://www.hitachichem.co.jp/english/index.html)
KKR STATEMENTS OF OPERATIONS SUPPLEMENTAL PRIOR PERIOD SEGMENT INFORMATION QUARTER ENDED MARCH 31, 2014 (Amounts in thousands)
QUARTER ENDED MARCH 31, 2014 Management Fees $ 123,039 $ 72,354 $ - $ 195,393 Monitoring Fees 36,363 - - 36,363 Transaction Fees 93,020 6,022 64,474 163,516 Fee Credits (80,338) (4,330) - (84,668) Total
Novelis Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (in millions)
Novelis Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (in millions) Three Months Ended March 31, Net sales $ 2,621 $ 2,402 $ 9,591 $ 9,872 Cost of goods sold (exclusive of depreciation
Consolidated Balance Sheets Consolidated Balance Sheet
Consolidated Balance Sheets Consolidated Balance Sheet As of 2017 2016 Current Assets Cash and cash equivalents $ 12,681 $ 9,968 Short-term investments 30,338 18,664 Trade receivables 30,662 19,788 Other
ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS June 30, 2016 (Reviewed) December 31, 2015 (Audited) June 30, 2015 (Reviewed) ASSETS Amount % Amount % Amount % CURRENT ASSETS Cash and cash equivalents $ 1,520,270 4 $ 2,639,717
INVESTOR SUMMARY. 2Q13 August 6, 2013
QUARTERLY INVESTOR SUMMARY 2Q13 August 6, 2013 DISH NETWORK REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS YOY subscriber-related revenue improves 5 percent Net loss driven by $438 million of impairment
Tera Probe, Inc. Financial Results. for the Second Quarter FY2017
Tera Probe, Inc. Financial Results for the Second Quarter FY2017 This document has been translated from Japanese original for reference purpose only. In the event of any discrepancy between this translated
NORTH KARANPURA TRANSMISSION COMPANY LIMITED ANNUAL ACCOUNTS FOR THE FY
NORTH KARANPURA TRANSMISSION COMPANY LIMITED ANNUAL ACCOUNTS FOR THE FY 2014-15 Vishal D Shah Partner Membership No. 119303 Place: Mumbai Date: Vishal D Shah Partner Membership No. 119303 Place: Mumbai
ASPEED TECHNOLOGY INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (In Thousands of New Taiwan Dollars) June 30, 2018 December 31, 2017 (Audited) June 30, 2017 June 30, 2018 December 31, 2017 (Audited) June 30, 2017 ASSETS Amount % Amount %
2
News Release 1 2 3 4 5 6 Ashland Global Holdings Inc. and Consolidated Subsidiaries Table 1 STATEMENTS OF CONSOLIDATED INCOME (LOSS) (In millions except per share data - preliminary and unaudited) Three
Consolidated Financial Summary (For the First Half Ended September 30, 2015 (IFRS basis))
Consolidated Financial Summary (For the First Half Ended September 30, 2015 (IFRS basis)) Listed company: Hitachi Chemical Co., Ltd. October 26, 2015 (Code number: 4217 Stock exchange: Tokyo) (URL http://www.hitachichem.co.jp/english/index.html)
RELIANCE SIBUR ELASTOMERS PRIVATE LIMITED Reliance Sibur Elastomers Private Limited
RELIANCE SIBUR ELASTOMERS PRIVATE LIMITED 1579 Reliance Sibur Elastomers Private Limited 1580 RELIANCE SIBUR ELASTOMERS PRIVATE LIMITED Independent Auditor's Report TO THE MEMBERS OF RELIANCE SIBUR ELASTOMERS
ACCENTURE PLC RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC)
RECONCILIATION OF RETURN ON INVESTED CAPITAL (ROIC) For the Twelve Months Ended (in millions of U.S. dollars) (Unaudited) ROIC represents Return on Invested Capital and is equal to the tax adjusted operating
Financial Report FIRST QUARTER REPORT
Financial Report 20 18 FIRST QUARTER REPORT The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. We have more ideas, we see more opportunities and we want to
Condensed consolidated statement of profit and loss Reported amounts (NIS in millions)
Condensed consolidated statement of profit and loss Interest revenues 1,449 1,356 6,222 Interest expenses 368 329 1,875 Interest revenues, net 1,081 1,027 4,347 Expenses with respect to credit losses 82
Major Differences between TIFRS and R.O.C. GAAP for TSMC
Page 1 Major Differences between TIFRS and R.O.C. GAAP for TSMC Starting 2013, TSMC prepares financial statements in accordance with TIFRS (International Financial Reporting Standards as endorsed for use
FINANCIAL RESULTS FOR THE YEAR ENDED MARCH 2014
FINANCIAL RESULTS FOR THE YEAR ENDED MARCH 2014 (IFRS) Mitsubishi Corporation 2-3-1 Marunouchi, Chiyoda-ku, Tokyo, JAPAN 100-8086 http://www.mitsubishicorp.com/ June 30, 2014 Mitsubishi Corporation 1.
2
1 2 3 4 5 6 Ashland Global Holdings Inc. and Consolidated Subsidiaries Table 1 STATEMENTS OF CONSOLIDATED INCOME (LOSS) (In millions except per share data - preliminary and unaudited) Three months ended
Consolidated Balance Sheets
Consolidated Balance Sheets March 31 2015 2016 2016 Assets: Current assets Cash and cash equivalents 726,888 600,897 $ 5,317,673 Marketable securities 19,033 28,012 247,894 Notes and accounts receivable: